[Federal Register Volume 60, Number 157 (Tuesday, August 15, 1995)]
[Notices]
[Page 42168]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-20104]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC) and 
Subcommittee on Proficiency Testing, Quality Assurance, and Quality 
Control; Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: Subcommittee on Proficiency Testing, Quality Assurance, 
and Quality Control, Clinical Laboratory Improvement Advisory 
Committee (CLIAC).
    Time and Date: 8:30 a.m.-12 noon, August 30, 1995.
    Place: Swissotel Atlanta, 3391 Peachtree Road, NE, Atlanta, 
Georgia 30326.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee advises CLIAC on issues related to 
proficiency testing, quality assurance, and quality control.
    Matters to be discussed: The Subcommittee will discuss quality 
control requirements for test method verification and appropriate 
materials for quality control testing.
    Agenda items are subject to change as priorities dictate.

    Name: Clinical Laboratory Improvement Advisory Committee.
    Times and Dates: 1 p.m.-4:30 p.m., August 30, 1995., 8 a.m.-4 
p.m., August 31, 1995.
    Place: Swissotel Atlanta, 3391 Peachtree Road, NE, Atlanta 
Georgia 30326.
    Status: Open to the public, limited only by the space available.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact of proposed revisions to the standards; and the modification 
of the standards to accommodate technological advances.
    Matters to be discussed: The agenda will include an update on 
the implementation of the Clinical Laboratory Improvement Amendments 
(CLIA), a CDC presentation on CLIA quality control requirements, 
public presentations on quality control requirements, a discussion 
of the quality control requirements for the final regulations, and a 
summary of the meeting of the Subcommittee on Proficiency Testing, 
Quality Assurance, and Quality Control.
    Agenda items are subject to change as priorities dictate.

    Written comments on the quality control requirements are welcome. 
Comments should not exceed five single-spaced, typed pages in length 
and should be received by the contact person no later than August 24, 
1995.
    Anyone wishing to make an oral presentation that would include data 
pertinent to CLIA quality control requirements should submit their 
request, in writing, to the contact person by close of business, August 
24, 1995. The request should include the name, address, and telephone 
number of the participant; the approximate time needed; and a brief 
summary of the topic and data to be presented. Depending on the number 
of requests, up to 10 minutes will be allowed for each oral 
presentation.

    Contact Person for addition information: John C. Ridderhof, Dr. 
P.H., Division of Laboratory Systems, Public Health Practice Program 
Office, CDC, 4770 Buford Highway, NE, Mailstop G-25, Atlanta, 
Georgia 30341-3724, telephone 404/488-7660, FAX 404-488-7663.

    Dated: August 9, 1995.
Carolyn J. Russell,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 95-20104 Filed 8-14-95; 8:45 am]
BILLING CODE 4163-18-M